Mirtazapine Tablet, Orally Disintegrating
Product Images NDC 57237-013

4 FDA label images from Rising Pharma Holdings, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 57237-013). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (15 mg Blister Carton (5 x 6 Unit-dose))

Package Label-principal Display Panel (15 mg Blister Carton (5 x 6 Unit-dose))
Packaging label for Mirtazapine Orally Disintegrating Tablets, USP 15 mg from Rising Pharma Holdings, Inc. The label indicates a once-a-day dosage form with 5 x 6 unit dose tablets per package. It includes warnings about child-resistance, storage conditions, and tablet removal instructions, with distribution by Rising Health, LLC and manufacturing in India.*
FDA Label Image

Package Label-principal Display Panel (30 mg Blister Carton (5 x 6 Unit-dose))

Package Label-principal Display Panel (30 mg Blister Carton (5 x 6 Unit-dose))
Packaging label for Mirtazapine Orally Disintegrating Tablets, USP 30 mg by Rising Pharma Holdings, Inc. The label shows unit dose packaging with 5 x 6 tablets, instructions for dispensing and removing tablets, storage conditions, and manufacturer details including distribution by Rising Health, LLC and made in India. The label features a blue and yellow design with the NDC 57237-012-06.*
FDA Label Image

Package Label-principal Display Panel (45 mg Blister Carton (5 x 6 Unit-dose))

Package Label-principal Display Panel (45 mg Blister Carton (5 x 6 Unit-dose))
Packaging label for Mirtazapine Orally Disintegrating Tablets, USP, 45 mg, manufactured by Rising Pharma Holdings, Inc. The label displays the drug as a once-a-day oral tablet in a 5 x 6 unit dose blister pack. It includes directions for pharmacists, storage instructions, and removal instructions for tablets from the blister pack. The product is labeled Rx only and is child-resistant.*
FDA Label Image

Chemical Structure (Mirtazapine Str)

Chemical Structure (Mirtazapine Str)
Chemical structure of mirtazapine, showing its polycyclic ring system including nitrogen atoms and a methyl group attached to the piperazine ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.